Healthcare Industry News: Axesse
News Release - April 26, 2012
Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to AtlantaLeading global provider of radiation therapy and radiosurgery systems joins Atlanta biomedical community
ATLANTA, April 26, 2012 -- (Healthcare Sales & Marketing Network) -- Elekta, a leading international technology and solutions provider for the treatment of cancer and brain disorders, is relocating its North America headquarters in 2012. Elekta's new HQ will be The Terraces in Atlanta's Central Perimeter business district. The company anticipates adding more than 100 new jobs over five years in the life sciences field, specifically in the medical device and healthcare IT sectors.
"Elekta's global influence in healthcare is increasing rapidly," says Elekta's President and CEO, Tomas Puusepp. "The move of our North America headquarters to Atlanta will support this trend and strengthen Atlanta's growing biomedical community."
Elekta will be a new asset in DeKalb County, according to Judy Turner, Chair, Development Authority of DeKalb County, Ga.
"Elekta is the type of innovative health care company that will add to the synergy of other life science assets already located in DeKalb County, such as the Centers for Disease Control and Emory Healthcare," she says. "The Development Authority of DeKalb County is very proud to be a partner with Elekta and is looking forward to their new facility in DeKalb County."
"Medical device companies such as Elekta represent a large proportion of our bioscience industry, so we're pleased Elekta has chosen to continue to grow and create jobs in Georgia," adds Chris Cummiskey, Commissioner of the Georgia Department of Economic Development. "We have terrific collaborations and research expertise in this area."
Elekta helps reinforce the fact that Atlanta is a leading location for international bioscience companies, according to Hans Gant, senior vice president of economic development for the Metro Atlanta Chamber.
"One of Atlanta's true strengths is having access to a highly talented workforce, which will help support the projected growth of Elekta's operations," he says.
"The expansion of Elekta's North American Headquarters is an excellent example of the partnership between the Georgia Department of Economic Development, Metro Atlanta Chamber, and the City of Dunwoody to cultivate new business for Georgia," said Economic Development Director Michael Starling. "Elekta is a true reflection of the state's and Dunwoody's strategy to recruit and grow world-class technology companies."
"The decision by Elekta to establish its North American headquarters in Dunwoody is the culmination of a truly collaborative and creative effort," said Jeff Estep, executive managing director of Newmark Knight Frank, the consultant to Elekta. "We conducted a thorough analysis of Elekta's needs and location options across North America, including in-depth review of business costs, talent availability, training and operational processes, and the Atlanta area proved itself to be the ideal location for the company's global growth objectives. We received incredible support from the State of Georgia, DeKalb County, the City of Dunwoody and the Metro Atlanta Chamber."
Elekta develops sophisticated tools and dose planning systems for radiation therapy and radiosurgery and brachytherapy, in addition to software systems that improve the efficiency of workflows throughout the spectrum of cancer care. Among its most recognized products are Elekta Synergy®, Elekta Infinity™ and Elekta Axesse™ radiation treatment systems (linear accelerators), Leksell Gamma Knife® Perfexion™ radiosurgery system for ultra-precise treatment of intracranial disease targets, MOSAIQ® oncology information system and Monaco® treatment planning system.
Employing about 3,300 people globally, Elekta markets its solutions in North and South America, Europe, the Middle East, Africa and Asia-Pacific countries.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.